Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81Leukemia 41Gastrointestinal Stromal Tumors 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Leukemia, Myeloid, Chronic-Phase 27Blast Crisis 13Neoplasms 10Neoplasm Metastasis 10Melanoma 10Brain Neoplasms 10Lung Neoplasms 9Prostatic Neoplasms 8Leukemia, Myeloid, Acute 8Gliosarcoma 8Glioblastoma 8Leukemia, Myeloid, Accelerated Phase 7Glioma 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 5Philadelphia Chromosome 5Oligodendroglioma 5Recurrence 4Primary Myelofibrosis 4Polycythemia Vera 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 4Astrocytoma 4

Interventions

Everolimus 3Capecitabine 3lutetium Lu 177 dotatate 2lenvatinib 2cabozantinib 2Thyroidectomy 2Temozolomide 2Sorafenib 2Magnetic Resonance Spectroscopy 2High-Energy Shock Waves 2veliparib 1vatalanib 1vandetanib 1temsirolimus 1selpercatinib 1sacubitril and valsartan sodium hydrate drug combination 1ponatinib 1pentetreotide 1pasireotide 1gallium Ga 68 dotatate 1fluorodopa F 18 1fludarabine 1cemiplimab 1Vinorelbine 1Thalidomide 1Surgical Procedures, Operative 1Sunitinib 1Specimen Handling 1Sirolimus 1Semaxinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Medullary × Imatinib Mesylate × Clear all
NCT00354523 2014-12-17

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated
21 enrolled
Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡